Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel H Wilks

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Biorxiv : the Preprint Server for Biology|November 18, 2024
A vaccine antigen central in influenza A(H5) virus antigenic space confers subtype-wide immunityAdinda Kok, Samuel H Wilks, Sina Tureli, et al.
Nature|October 15, 2025
A vaccine central in A(H5) influenza antigenic space confers broad immunityAdinda Kok, Samuel H Wilks, Sina Tureli, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2024
Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariantsBarbara Mühlemann, Jakob Trimpert, Felix Walper, et al.
Science Translational Medicine|April 1, 2026
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B virusesThi H O Nguyen, Isabelle J H Foo, Ruth A Purcell, et al.
Biorxiv : the Preprint Server for Biology|July 21, 2022
Mapping SARS-CoV-2 antigenic relationships and serological responsesSamuel H Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
Science (New York, N.Y.)|October 5, 2023
Mapping SARS-CoV-2 antigenic relationships and serological responsesSamuel H Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model SeraBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Science Translational Medicine|May 15, 2024
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assaysBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Nature Medicine|August 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2022
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|November 18, 2024
A vaccine antigen central in influenza A(H5) virus antigenic space confers subtype-wide immunityAdinda Kok, Samuel H Wilks, Sina Tureli, et al.
Nature|October 15, 2025
A vaccine central in A(H5) influenza antigenic space confers broad immunityAdinda Kok, Samuel H Wilks, Sina Tureli, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2024
Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariantsBarbara Mühlemann, Jakob Trimpert, Felix Walper, et al.
Science Translational Medicine|April 1, 2026
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B virusesThi H O Nguyen, Isabelle J H Foo, Ruth A Purcell, et al.
Biorxiv : the Preprint Server for Biology|July 21, 2022
Mapping SARS-CoV-2 antigenic relationships and serological responsesSamuel H Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
Science (New York, N.Y.)|October 5, 2023
Mapping SARS-CoV-2 antigenic relationships and serological responsesSamuel H Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model SeraBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Science Translational Medicine|May 15, 2024
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assaysBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Nature Medicine|August 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2022
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Pageof 3